We are to email two newsletters a year to members in future. David Casley, Prospect Publicity 07860 369064; Email  prospect.bristol@gmail.com

News

New screening trial

Prostate Cancer UK is launching a £42m research programme – the TRANSFORM trial – to find the best way to screen men for PCa, so one day all men at risk are invited for regular tests to find aggressive cancers in time for a cure. More here

Making hormone therapy work longer

Researchers find new approaches to hormone therapy to keep it working for longer. More here

Cancer language ‘must change’

Let King Charles’s illness finally change how we speak about cancer: it’s not about ‘winning’ or ‘losing’ a ‘war’, writes Simon Jenkins in the Guardian. As someone treated for bowel cancer, he thinks attitudes must change but also the language. Some of it is tactless, some ridiculous. More here

13 new test centres

The government has announced 13 new diagnostic centres, enabling the NHS to perform nearly 750,000 more PCa tests and checks each year, says Prostate Cancer Research (Dec ’23).

Treatment ‘breakthrough’

Resistance to normal treatment for advanced PCa may be reversed in some men by stopping white blood cells from being “hijacked” and pulled into tumours, say researchers (2023) More here

Sex and PCa

How to keep your prostate healthy? Have more sex. See more here And more help here

Memorial in Lincoln

The PCa memorial is now in Waterside Shopping Centre, Lincoln, and will stay until March 12. The link to add a name has closed for now but a new date will be announced.

 

 

Wellbeing hub launched

Prostate Cancer UK have created this wellbeing hub to help support you in looking after your emotional, mental, and physical wellbeing. More here. And Prostate Cancer Research has more advice on that here

Diabetes drug finding

The diabetes drug metformin could prevent the progression of PCa but only for some tumours which are more likely to develop into aggressive cancers. More here

Missing out on drug

Thousands of English men missing out on abiraterone. See here